Author:
Wafa Abdulsamad,Moassass Faten,Liehr Thomas,Bhatt Samarth,Aljapawe Abdulmunim,Al Achkar Walid
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,Biochemistry
Reference35 articles.
1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopietic and lymphoid tissues. 4th ed. Lyon: WHO Press; 2008. p. 224–5.
2. de-Jong D, de-Boer JP. Predicting transformation in follicular lymphoma. Leuk Lymphoma. 2009;50:1406–11.
3. De-Jong D, Voetdijk BM, Beverstock GC, Van-Ommen GJ, Willemze R, Kluin PM. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med. 1988;318:1373–8.
4. Gauwerky CE, Haluska FG, Tsujimoto Y, Nowell PC, Croce CM. Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene. Proc Natl Acad Sci U S A. 1988;85:8548–52.
5. Hubbard SM, Chabner BA, DeVita VT, Simon R, Berard CW, Jones RB, et al. Histologic progression in non-Hodgkin’s lymphoma. Blood. 1982;59:258–64.